A s doctors and researchers learn more about Ozempic's health benefits, many are impressed. Besides lowering blood sugar in ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

While Ozempic has been shown to lead to weight loss as a side effect, it's not without risks. According to the Cleveland ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

Ozempic is only FDA-approved for treating type-2 diabetes, but doctors can prescribe it “off-label”—or for a purpose that isn’t approved by the FDA—because semaglutide has documented ...

The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...

It was semaglutide, a drug sold under the brand names Ozempic (for diabetes ... weight loss drugs on those with lower BMIs ...

Certain GLP-1 medications, like Ozempic, are only FDA-approved for type 2 diabetes ... Still, plenty are prescribed off-label ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...